Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03180372 · ClinicalTrials.gov registry record · NA

Hybrid Fractional Laser Treatment for Symptoms of Urinary Incontinence

A NA study, sponsored by Sciton.

Completed
Registry status
NA
Development phase
51
Enrollment target

NCT03180372 is a NA study that has completed, run by Sciton. The registered enrollment target is 51 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03180372, a NA study, has completed, sponsored by Sciton.

COMPLETED
Registry status
NA
Development phase
51 participants
Enrollment target

Study Summary

This multi-center clinical trial will evaluate the safety and long-term efficacy of hybrid fractional 2940 nm and 1470 lasers for improvement of symptoms of urinary incontinence.

Interventions

  • DEVICE Hybrid Fractional Laser

Trial Details

FieldValue
Enrollment Target 51 participants
Start Date 2017-05-19
Est. Completion 2019-11-30
Phase NA

Sponsor

Sciton

12 total trials

What the Registry Record Tells You About NCT03180372

The ClinicalTrials.gov registry entry for NCT03180372 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 51 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sciton, which has 12 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Hybrid Fractional Laser is the first listed.

NCT03180372 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03180372 about?

NCT03180372 is a clinical study titled "Hybrid Fractional Laser Treatment for Symptoms of Urinary Incontinence". This multi-center clinical trial will evaluate the safety and long-term efficacy of hybrid fractional 2940 nm and 1470 lasers for improvement of symptoms of urinary incontinence.

What is the current status of trial NCT03180372?

This trial is currently completed. It is a NA study. The enrollment target is 51 participants. The study started on 2017-05-19. Estimated completion is 2019-11-30.

What interventions are being tested in trial NCT03180372?

The interventions under investigation include: Hybrid Fractional Laser (DEVICE).

Who is sponsoring clinical trial NCT03180372?

This trial is sponsored by Sciton, which has 12 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.